BridgeMD
New treatment option for Parkinson Disease
Official title Cortical-Basal Ganglia Speech Networks
ClinicalTrials.gov ID: NCT04286308
What this study is testing
- What it's testing
- In this research study the researchers want to learn more about brain activity related to speech perception and production.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- people scheduled for DBS implantation, as determined by the clinical multidisciplinary movement disorders board with definitive diagnosis of...
- people able to provide informed consent and comply with task instructions.
- people 18-85 years old
You likely can't join if
- people with reported hearing loss.
- Non-English-speaking people
The study team makes the final eligibility decision.
Where it's taking place
- Boston, Massachusetts, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Boston, Massachusetts, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.